Pep31

1 study on Pep31 curated from PubMed, ClinicalTrials.gov, and EuropePMC. Updated daily.

Bottom line: TitrateLab currently curates 1 dated study on Pep31. The source summaries below describe published research; they do not establish product quality, safety, or clinical suitability.

Pep31 studies and clinical research

2026-04-28 PubMed · in vitro · n preclinical

Moringa Peptides Show Promise Against Deadly CCHFV Protease

This study provides a significant computational foundation for developing novel antiviral therapies against CCHFV, a pathogen with urgent unmet medical needs and a high fatality rate. By specifically targeting the uni…

Research tools

Free, no account — handy when you're working with Pep31.

Reconstitution calculator Bac water, concentration & insulin-unit math Verify a COA Look up a report number against our corpus

TitrateLab PRO

Unlock the complete evidence trail

Pro members save studies and unlock the full evidence breakdown and vendor lab data.

Complete vendor lab histories
Every linked certificate on file
Batch-level purity and quantity detail
Thousands of community reviews

Buyer protection: Wrong or defective product? Report it within 7 days. We broker a refund or reship with the vendor.

$12 monthly or $33 lifetime

Create free account

TitrateLab

You must be 21 or older to enter.

TitrateLab provides research-use information on peptides for adults. Confirm your age to continue.

For research purposes only. Not for human consumption. By entering you agree to our Terms & Privacy.

Pep31 studies and clinical research

Moringa Peptides Show Promise Against Deadly CCHFV Protease

Research tools